Ballinger JR et al. |
Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour models. |
2003 |
Nucl Med Commun |
pmid:12717079
|
Liu Z et al. |
99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice. |
2004 |
Nucl Med Commun |
pmid:15208499
|
Liu Z et al. |
Evaluating the protective role of ischaemic preconditioning in rat hearts using a stationary small-animal SPECT imager and 99mTc-glucarate. |
2008 |
Nucl Med Commun |
pmid:18094633
|
Petrov AD et al. |
Targeting human breast tumour in xeno-grafted SCID mice with 99Tcm-glucarate. |
1997 |
Nucl Med Commun |
pmid:9106778
|
Micheletti C et al. |
[Enzyme induction during treatment with isoniazid]. |
1978 Aug 26-Sep 2 |
Nouv Presse Med |
pmid:693296
|
Hartikka P et al. |
Effect of iron-saccharin injections of Finnish horses. |
1983 May-Jun |
Nord Vet Med |
pmid:6889132
|
Okuyama T et al. |
[Measurement and its fluctuation of urinary glucaric acid in newborns]. |
1993 |
Nippon Sanka Fujinka Gakkai Zasshi |
pmid:8340644
|
Mizumoto Y et al. |
[Measurement and fluctuation of urinary glucaric acid in pregnant women]. |
1994 |
Nippon Sanka Fujinka Gakkai Zasshi |
pmid:8089594
|
Wada Y et al. |
[Case report; A case of FGF23-related hypophosphatemic osteomalacia caused by long-term administration of saccharated ferric oxide]. |
2011 |
Nippon Naika Gakkai Zasshi |
pmid:22175146
|
Okada M et al. |
[2 cases of nonspecific multiple ulcers of the small intestine associated with osteomalacia caused by long-term intravenous administration of saccharated ferric oxide]. |
1982 |
Nippon Naika Gakkai Zasshi |
pmid:7166673
|
Konjiki O et al. |
[A case of hypophosphatemia induced by intravenous administration of saccharated iron oxide]. |
1994 |
Nihon Ronen Igakkai Zasshi |
pmid:7853746
|
Ogi M et al. |
[Comparison of intravenous ascorbic acid versus intravenous iron for functional iron deficiency in hemodialysis patients]. |
2004 |
Nihon Jinzo Gakkai Shi |
pmid:15645737
|
Masaki H |
[Metabolic pathway of D-glucaric acid synthesis from D-glucuronolactone in the skin. II. Identification of the intermediates in D-glucuronolactone D-glucaric acid metabolism]. |
1972 |
Nihon Hifuka Gakkai Zasshi |
pmid:4540858
|
Nasaki H |
[Metabolic pathway of D-glucaric acid synthesis from D-glucuronolactone in the skin. 1. D-glucaric acid and D-glucuronolactone dehydrogenase activities in the human skin--feedback mechanism of beta-glucuronidase]. |
1972 |
Nihon Hifuka Gakkai Zasshi |
pmid:4540880
|
de Wolff FA et al. |
Serum concentrations and enzyme induction in epileptic children treated with phenytoin and valproate. |
1982 |
Neuropediatrics |
pmid:6123089
|
Koller WC et al. |
Metabolism of glucurolactone to glucarate in Parkinson's disease. |
1992 |
Neurology |
pmid:1513472
|
Ciuffi M et al. |
Lipid peroxidation induced "in vivo" by iron-carbohydrate complex in the rat brain cortex. |
1991 |
Neurochem. Res. |
pmid:2052138
|
Frezza M et al. |
Abnormal serum gamma-glutamyltranspeptidase in alcoholics. Clues to its explanation. |
1989 |
Neth J Med |
pmid:2563572
|
Sheashaa H et al. |
Parenteral iron therapy in treatment of anemia in end-stage renal disease patients: a comparative study between iron saccharate and gluconate. |
2005 |
Nephron Clin Pract |
pmid:15692217
|
Stefánsson BV et al. |
Acute oxidative stress following intravenous iron injection in patients on chronic hemodialysis: a comparison of iron-sucrose and iron-dextran. |
2011 |
Nephron Clin Pract |
pmid:21196770
|
Charytan C et al. |
Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products. |
2004 |
Nephron Clin Pract |
pmid:14988600
|
Descombes E and Fellay G |
Improved response to erythropoietin therapy with long-term continuous iron supplementation. |
2000 |
Nephron |
pmid:10657727
|
Silverberg DS et al. |
Intravenous ferric saccharate as an iron supplement in dialysis patients. |
1996 |
Nephron |
pmid:8852489
|
Tiranathanagul K et al. |
Oxidative stress from rapid versus slow intravenous iron replacement in haemodialysis patients. |
2004 |
Nephrology (Carlton) |
pmid:15363053
|
Wu CJ et al. |
Comparison of parenteral iron sucrose and ferric chloride during erythropoietin therapy of haemodialysis patients. |
2010 |
Nephrology (Carlton) |
pmid:20377770
|
Garcia-Fernandez N et al. |
Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis. |
2010 |
Nephrology (Carlton) |
pmid:20470276
|
Ozdemir A et al. |
Relationship between iron replacement and hepatic functions in hepatitis C virus-positive chronic haemodialysis patients. |
2005 |
Nephrology (Carlton) |
pmid:16221090
|
Ranfaing E |
[Treatments of the martial deficiencies: preparations available in France]. |
2006 |
Nephrol. Ther. |
pmid:17373280
|
Stoves J et al. |
A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. |
2001 |
Nephrol. Dial. Transplant. |
pmid:11328902
|
Carlini RG et al. |
Apoptotic stress pathway activation mediated by iron on endothelial cells in vitro. |
2006 |
Nephrol. Dial. Transplant. |
pmid:16957011
|
Schiesser D et al. |
Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients. |
2006 |
Nephrol. Dial. Transplant. |
pmid:16891647
|
Guz G et al. |
Impact of iron sucrose therapy on leucocyte surface molecules and reactive oxygen species in haemodialysis patients. |
2006 |
Nephrol. Dial. Transplant. |
pmid:16762960
|
Chuang CL et al. |
Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. |
2003 |
Nephrol. Dial. Transplant. |
pmid:12543894
|
Parkkinen J et al. |
Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration. |
2000 |
Nephrol. Dial. Transplant. |
pmid:11071973
|
Fell LH et al. |
Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells. |
2016 |
Nephrol. Dial. Transplant. |
pmid:27190361
|
Silverberg D et al. |
The use of androgens in anaemia resistant to erythropoietin and i.v. iron in patients with heart and renal failure. |
2004 |
Nephrol. Dial. Transplant. |
pmid:15031380
|
Airy M et al. |
Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. |
2015 |
Nephrol. Dial. Transplant. |
pmid:26311216
|
Bhandari S et al. |
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients. |
2015 |
Nephrol. Dial. Transplant. |
pmid:25925701
|
Onken JE et al. |
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. |
2014 |
Nephrol. Dial. Transplant. |
pmid:23963731
|
McMahon LP et al. |
Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial. |
2010 |
Nephrol. Dial. Transplant. |
pmid:19906658
|
Rottembourg J et al. |
Do two intravenous iron sucrose preparations have the same efficacy? |
2011 |
Nephrol. Dial. Transplant. |
pmid:21355067
|
Wang S et al. |
Chemical reactions of vitamin C with intravenous-iron formulations. |
2008 |
Nephrol. Dial. Transplant. |
pmid:17951305
|
al-Hawas F et al. |
Use of i.v. iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin. |
1997 |
Nephrol. Dial. Transplant. |
pmid:9430909
|
Sunder-Plassmann G and Hörl WH |
Safety of intravenous injection of iron saccharate in haemodialysis patients. |
1996 |
Nephrol. Dial. Transplant. |
pmid:8918625
|
George P et al. |
Coronary artery vasospasm with iron sucrose. |
2007 |
Nephrol. Dial. Transplant. |
pmid:17327282
|
Sunder-Plassmann G et al. |
The dilemma of evaluating iron status in dialysis patients--limitations of available diagnostic procedures. |
1997 |
Nephrol. Dial. Transplant. |
pmid:9269632
|
Lim PS et al. |
Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. |
1999 |
Nephrol. Dial. Transplant. |
pmid:10534512
|
Edwards JH |
Clinical review of the newer intravenous iron therapy options. |
2003 |
Nephrol Nurs J |
pmid:12674953
|
Folkert VW |
Intravenous iron therapy in chronic kidney disease and peritoneal dialysis patients. |
2003 |
Nephrol Nurs J |
pmid:14621635
|
Colfer M |
Achieving optimal patient outcomes with intravenous iron. |
2003 |
Nephrol Nurs J |
pmid:14533524
|